Search Materials

This report summarizes data from the national TB surveillance system for 2004 and describes trends since 1993. Findings indicate that although the 2004 TB rate was the lowest recorded in the United States since national reporting began in 1953, the declines in rates for 2003 (2.3%) and 2004 (3.3%) were the smallest since 1993...

This is an achievement report about the Global Drug Facility (GDF), a key initiative of the STOP TB Partnership, which has had a positive impact on the treatment of millions of TB patients globally since its establishment in 2001. By providing high-quality TB drugs to over 4.4 million people in some of the world's poorest countries, it has helped to save lives and has significantly strengthened global TB control efforts.

This report summarizes the recommendations of the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services. The report describes in greater detail the actions and performance measures that were used to guide development and implementation of an integrated system for providing TB laboratory services...

This fact sheet uses a question-and-answer format to provide the general public with information on TB. It discusses TB disease and infection, transmission, symptoms, diagnosis, and treatment.

This report is the proceedings of the Tuberculosis Behavioral and Social Science Research Forum held on December 10-11, 2003 in Atlanta, GA. The Forum's goal was to identify and prioritize TB behavioral and social science research needs, so that a research agenda for TB prevention, control, and treatment could be developed...

This report is an outline of the Expert Consultation on TB/HIV Research Priorities in Resource-limited Setting on 14-16 February 2005 in Geneva, Switzerland. Three discussion groups identified research priorities for five major areas: (1) preventive therapy for TB were identified with a distinction between the population and the individual levels; (2) co-trimoxazole prophylaxis including the role of co-trimoxazole in the context of antiretroviral therapy, delivery strategies, and determining the efficacy of and optimal time for initiating co-trimoxazole prophylaxis among people living with HIV/AIDS and TB; (3) antiretroviral therapy for people living with HIV/AIDS who have TB or who develop TB is validating the optimal time for initiating antiretroviral therapy; (4) intensified case-finding focus on ways to put this TB/HIV collaborative activity into operation to improve TB control; and (5) the development of new tools and diagnostic algorithms to improve the diagnosis of smear-negative TB in adults and children.

This report, from the National Tuberculosis Controllers Association and CDC, is an update of the American Thoracic Society guidelines on the investigation, diagnostic evaluation, and medical treatment of TB contacts published in 1976. These revised guidelines provide recommendations concerning investigation of TB exposure and transmission and prevention of future cases of TB through contact investigation.

This publication, developed by the WHO Stop TB Partnership, is a training course that consists of 14 modules, including a facilitator guide and answer sheets. This course provides District TB Coordinators the skills and knowledge needed to plan, supervise, implement, monitor and evaluate the activities of a district TB control program...

This card provides a place for health professionals to record tuberculin skin test results, QFT result, chest x-ray date, TB status, the medical treatment being administered, and contact information for the service provider. The card is given to the patient to serve as a permanent record of TB status.

This booklet is one of several culturally-appropriate patient education materials produced by the Centers for Disease Control and Prevention and the New Jersey Medical School Global Tuberculosis Institute. All of these patient education materials can be found on the following webpage: www.cdc.gov/tb/pubs/CulturalMaterials...